JP6221536B2 - Composition for external use - Google Patents
Composition for external use Download PDFInfo
- Publication number
- JP6221536B2 JP6221536B2 JP2013189093A JP2013189093A JP6221536B2 JP 6221536 B2 JP6221536 B2 JP 6221536B2 JP 2013189093 A JP2013189093 A JP 2013189093A JP 2013189093 A JP2013189093 A JP 2013189093A JP 6221536 B2 JP6221536 B2 JP 6221536B2
- Authority
- JP
- Japan
- Prior art keywords
- purified water
- minoxidil
- heated
- aqueous solution
- polyvinyl alcohol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title description 52
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 claims description 76
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 claims description 69
- 229960003632 minoxidil Drugs 0.000 claims description 69
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 53
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 52
- 229920002125 Sokalan® Polymers 0.000 claims description 51
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 38
- 239000006071 cream Substances 0.000 claims description 35
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 22
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 15
- 229940058015 1,3-butylene glycol Drugs 0.000 claims description 11
- 235000019437 butane-1,3-diol Nutrition 0.000 claims description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 10
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 8
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 8
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 8
- 239000005642 Oleic acid Substances 0.000 claims description 8
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 8
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 8
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 8
- 150000005846 sugar alcohols Polymers 0.000 claims description 7
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 5
- 235000011187 glycerol Nutrition 0.000 claims description 5
- 238000007127 saponification reaction Methods 0.000 claims description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 89
- 239000008213 purified water Substances 0.000 description 88
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 81
- 239000007864 aqueous solution Substances 0.000 description 81
- 239000003921 oil Substances 0.000 description 48
- 235000019198 oils Nutrition 0.000 description 48
- 239000008346 aqueous phase Substances 0.000 description 44
- 239000012071 phase Substances 0.000 description 44
- 238000002360 preparation method Methods 0.000 description 24
- 238000003756 stirring Methods 0.000 description 22
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 19
- 229940043276 diisopropanolamine Drugs 0.000 description 19
- 230000000052 comparative effect Effects 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- 238000009472 formulation Methods 0.000 description 11
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 4
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 4
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 4
- 230000003779 hair growth Effects 0.000 description 4
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 3
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 229940031578 diisopropyl adipate Drugs 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 2
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 2
- FWKQNCXZGNBPFD-UHFFFAOYSA-N Guaiazulene Chemical compound CC(C)C1=CC=C(C)C2=CC=C(C)C2=C1 FWKQNCXZGNBPFD-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- -1 etc.) Substances 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 2
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000001587 sorbitan monostearate Substances 0.000 description 2
- 235000011076 sorbitan monostearate Nutrition 0.000 description 2
- 229940035048 sorbitan monostearate Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- ZIMGGGWCDYVHOY-UHFFFAOYSA-N 3-hydroxy-2-imino-6-(1-piperidinyl)-4-pyrimidinamine Chemical compound N=C1N(O)C(N)=CC(N2CCCCC2)=N1 ZIMGGGWCDYVHOY-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 235000015701 Artemisia arbuscula Nutrition 0.000 description 1
- 235000002657 Artemisia tridentata Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 235000002568 Capsicum frutescens Nutrition 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 235000015655 Crocus sativus Nutrition 0.000 description 1
- 244000124209 Crocus sativus Species 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 241000546188 Hypericum Species 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 description 1
- 241001527087 Panax vietnamensis Species 0.000 description 1
- 235000017726 Panax vietnamensis Nutrition 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 241001247145 Sebastes goodei Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 240000002299 Symphytum officinale Species 0.000 description 1
- 235000005865 Symphytum officinale Nutrition 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- RZMKWKZIJJNSLQ-UHFFFAOYSA-M carpronium chloride Chemical compound [Cl-].COC(=O)CCC[N+](C)(C)C RZMKWKZIJJNSLQ-UHFFFAOYSA-M 0.000 description 1
- 229950003631 carpronium chloride Drugs 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 229960002350 guaiazulen Drugs 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 229950004864 olamine Drugs 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- OIQJEQLSYJSNDS-UHFFFAOYSA-N piroctone Chemical compound CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O OIQJEQLSYJSNDS-UHFFFAOYSA-N 0.000 description 1
- 229950001046 piroctone Drugs 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- TXGSOSAONMOPDL-UHFFFAOYSA-N propan-2-yl 3,4,5-trihydroxybenzoate Chemical compound CC(C)OC(=O)C1=CC(O)=C(O)C(O)=C1 TXGSOSAONMOPDL-UHFFFAOYSA-N 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 235000013974 saffron Nutrition 0.000 description 1
- 239000004248 saffron Substances 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 229940037001 sodium edetate Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- UIERGBJEBXXIGO-UHFFFAOYSA-N thiamine mononitrate Chemical compound [O-][N+]([O-])=O.CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N UIERGBJEBXXIGO-UHFFFAOYSA-N 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
本発明は、ミノキシジルを含有するクリーム剤に関する。さらに詳しくは、製剤の安定性及び使用感に優れたミノキシジル含有クリーム剤に関する。 The present invention relates to a cream containing minoxidil. More specifically, the present invention relates to a minoxidil-containing cream that is excellent in the stability and usability of the preparation.
ミノキシジルは化学名を6−(1−ピペリジニル)−2,4−ピリミジンジアミン−3−オキサイドと称し、発毛剤としての適応が知られている(特許文献1参照)。ミノキシジルは、外用塗布により優れた育毛・発毛効果を発揮する薬剤であり、ローションタイプのミノキシジル含有外用剤が国内外で市販されている。
しかしながら、ローションタイプの製剤では、使用時に液だれが起こることが懸念される。そのため、液だれのないミノキシジル含有外用組成物が望まれているが、液だれが十分に抑えられたミノキシジル含有外用組成物は、未だに提供されていないというのが実状であった。
一方、ミノキシジルは水にほとんど溶解せず、アルコールに溶解しやすいという性質を有するため、国内外で市販されているミノキシジル含有外用組成物は、みな多量のアルコールを含有している。したがって、アルコールに過敏な人たちも安心して使用できる、刺激性の低いミノキシジル含有製品が望まれている。
液だれを十分に抑えることができる製剤としてクリーム剤が考えられるが、ミノキシジルを含有し、製剤が安定かつ使用感が良好で、アルコール濃度の低い、低刺激性のクリーム剤については知られていない。
Minoxidil has a chemical name of 6- (1-piperidinyl) -2,4-pyrimidinediamine-3-oxide and is known to be used as a hair growth agent (see Patent Document 1). Minoxidil is a drug that exhibits an excellent hair growth and hair growth effect when applied externally, and lotion-type minoxidil-containing external preparations are commercially available in Japan and overseas.
However, with a lotion type preparation, there is a concern that dripping may occur during use. Therefore, a minoxidil-containing external composition free from dripping is desired, but the actual situation is that a minoxidil-containing external composition with sufficiently suppressed dripping has not yet been provided.
On the other hand, since minoxidil has a property that it hardly dissolves in water and easily dissolves in alcohol, minoxidil-containing compositions for external use marketed domestically and abroad contain a large amount of alcohol. Therefore, there is a demand for a product that contains minoxidil that is less irritating and that can be used with peace of mind by people who are sensitive to alcohol.
A cream is considered as a preparation that can sufficiently suppress dripping, but there is no known low-irritant cream that contains minoxidil, has a stable preparation and good usability, and has a low alcohol concentration. .
本発明者らは、ミノキシジル含有クリーム剤に関し、ミノキシジルを十分溶解でき、安定で使用感が良好であり、かつアルコール濃度の低い低刺激性のミノキシジル含有外用組成物を提供することを課題とする。 It is an object of the present invention to provide a minoxidil-containing external composition that can sufficiently dissolve minoxidil, is stable, has a good feeling of use, and has a low alcohol concentration and is low in irritation.
本発明者らは、上記課題を解決すべく鋭意検討を重ねた結果、ミノキシジル、特定の油、カルボキシビニルポリマー及び部分けん化ポリビニルアルコールを含有するクリーム剤は、通常ミノキシジルを溶解させるために必要な多量の低級アルコールを含有せずにミノキシジルを十分溶解でき、安定で使用感にも優れることを見出し、本発明を完成するに至った。 As a result of intensive studies to solve the above problems, the present inventors have found that a cream containing minoxidil, a specific oil, a carboxyvinyl polymer and a partially saponified polyvinyl alcohol usually requires a large amount necessary for dissolving minoxidil. The present inventors have found that minoxidil can be sufficiently dissolved without containing any lower alcohol, and is stable and excellent in usability, thereby completing the present invention.
すなわち本発明は、
(1)ミノキシジル、イソステアリン酸及び/またはオレイン酸、カルボキシビニルポリマー、部分けん化ポリビニルアルコール、及び10w/w%未満の低級アルコールを含有することを特徴とするクリーム剤、
(2)さらに多価アルコールを含有することを特徴とする(1)に記載のクリーム剤、
(3)多価アルコールが、1,3−ブチレングリコール、ジプロピレングリコール、グリセリン及びプロピレングリコールからなる群から選ばれる1種または2種以上である(2)に記載のクリーム剤、
(4)pHが4.5〜9である(1)〜(3)のいずれかに記載のクリーム剤、
である。
That is, the present invention
(1) A cream characterized by containing minoxidil, isostearic acid and / or oleic acid, carboxyvinyl polymer, partially saponified polyvinyl alcohol, and less than 10 w / w% lower alcohol,
(2) The cream according to (1), further comprising a polyhydric alcohol,
(3) The cream according to (2), wherein the polyhydric alcohol is one or more selected from the group consisting of 1,3-butylene glycol, dipropylene glycol, glycerin and propylene glycol,
(4) The cream according to any one of (1) to (3), wherein the pH is 4.5 to 9,
It is.
本発明により、ミノキシジルを溶解でき、皮膚への刺激性が低く、かつ、安定性及び使用感に優れるミノキシジル含有クリーム剤を提供することが可能になった。 INDUSTRIAL APPLICABILITY According to the present invention, it is possible to provide a minoxidil-containing cream that can dissolve minoxidil, has low skin irritation, and is excellent in stability and use feeling.
本発明において用いるミノキシジルは、通常医薬品に用いられる品質のものを適宜使用することができる。ミノキシジルの含有量は、クリーム剤中1〜10w/w%であり、好ましくは1〜5w/w%である。 As the minoxidil used in the present invention, those having the quality usually used for pharmaceuticals can be appropriately used. The content of minoxidil is 1 to 10 w / w%, preferably 1 to 5 w / w% in the cream.
本発明において用いる油成分であるイソステアリン酸及び/またはオレイン酸は、どちらか一方でも、組み合わせて使用しても良い。イソステアリン酸及び/またはオレイン酸の含有量は、クリーム剤中1〜30w/w%、好ましくは3〜10w/w%である。 Either or both of isostearic acid and / or oleic acid, which are oil components used in the present invention, may be used in combination. The content of isostearic acid and / or oleic acid is 1 to 30 w / w%, preferably 3 to 10 w / w% in the cream.
本発明におけるカルボキシビニルポリマーとは、アクリル酸の共重合体を意味し、例えば、0.5%水溶液の粘度が4000〜10000mPa・s、40000〜60000mPa・sなどの粘度の異なるいくつかのタイプがあるが、本発明では粘度の高いタイプを主に用いるのが好ましい。カルボキシビニルポリマーの含有量は、クリーム剤中0.1〜3.0w/w%が好ましく、更に好ましくは0.1〜2.0w/w%であり、最も好ましいのは0.1〜0.8w/w%である。この含有量の範囲が、使用感が良く、安定性の高いO/Wエマルション型のクリーム剤を得ることができるためである。 The carboxyvinyl polymer in the present invention means a copolymer of acrylic acid. For example, there are several types having different viscosities such as viscosity of a 0.5% aqueous solution of 4000 to 10000 mPa · s and 40000 to 60000 mPa · s. However, in the present invention, it is preferable to mainly use a high viscosity type. The content of the carboxyvinyl polymer is preferably 0.1 to 3.0 w / w% in the cream, more preferably 0.1 to 2.0 w / w%, and most preferably 0.1 to 0.0. It is 8 w / w%. This is because the range of this content can provide an O / W emulsion-type cream with good usability and high stability.
本発明における部分けん化ポリビニルアルコールとは、酢酸ビニルを重合して得られるポリ酢酸ビニルを部分的にけん化したものを意味し、例えば、4%水溶液の粘度が4.8〜5.8mPa・s、20.5〜24.5mPa・s、27.0〜33.0mPa・s、40.0〜46.0mPa・sなどの粘度の異なるいくつかのタイプがあるが、本発明はそれら分子量や粘度に関係なく、一般に使用されているけん化度が70〜96mol%のものを使用すれば、安定なO/Wエマルション型のクリーム剤を製造することができる。製剤化や使用感の観点から、けん化度が78〜96mol%の部分けん化ポリビニルアルコールが好ましく、特にけん化度が85〜90mol%の部分けん化ポリビニルアルコールが好ましい。部分けん化ポリビニルアルコールの含有量は、組成物の全量に対して0.1〜4.0w/w%が好ましく、更に好ましくは0.1〜3.0w/w%であり、最も好ましいのは0.1〜1.2w/w%である。 The partially saponified polyvinyl alcohol in the present invention means a partially saponified polyvinyl acetate obtained by polymerizing vinyl acetate. For example, the viscosity of a 4% aqueous solution is 4.8 to 5.8 mPa · s, There are several types with different viscosities such as 20.5 to 24.5 mPa · s, 27.0 to 33.0 mPa · s, and 40.0 to 46.0 mPa · s. Regardless, if a saponification degree generally used is 70 to 96 mol%, a stable O / W emulsion type cream can be produced. From the viewpoints of formulation and usability, partially saponified polyvinyl alcohol having a saponification degree of 78 to 96 mol% is preferable, and partially saponified polyvinyl alcohol having a saponification degree of 85 to 90 mol% is particularly preferable. The content of the partially saponified polyvinyl alcohol is preferably 0.1 to 4.0 w / w%, more preferably 0.1 to 3.0 w / w%, most preferably 0 with respect to the total amount of the composition. 0.1 to 1.2 w / w%.
本発明における低級アルコールとは、エタノール、イソプロパノール等であり、好ましくはエタノールである。低級アルコールのクリーム剤中の含有量は10w/w%未満である。10w/w%以上の配合は、皮膚への刺激性の点だけでなく、本発明のクリーム剤の安定性が著しく悪化するため好ましくない。 The lower alcohol in the present invention is ethanol, isopropanol or the like, preferably ethanol. The content of the lower alcohol in the cream is less than 10 w / w%. The blending of 10 w / w% or more is not preferable because not only the irritation to the skin but also the stability of the cream of the present invention is significantly deteriorated.
本発明のクリーム剤には、使用感向上の点から、さらに多価アルコールを配合するのが好ましい。そのような多価アルコールとしては、1,3−ブチレングリコール、ジプロピレングリコール、グリセリン及びプロピレングリコール等が挙げられ、2種以上配合してもよい。多価アルコールの含有量は、使用感の点からクリーム剤中5〜30w/w%が好ましく、より好ましくは10〜15w/w%である。 The cream of the present invention preferably further contains a polyhydric alcohol from the viewpoint of improving the feeling of use. Examples of such a polyhydric alcohol include 1,3-butylene glycol, dipropylene glycol, glycerin, propylene glycol, and the like, and two or more kinds may be blended. The content of the polyhydric alcohol is preferably 5 to 30 w / w%, more preferably 10 to 15 w / w% in the cream from the point of use feeling.
本発明のクリーム剤のpHは、4.5〜9に調整することが好ましい。pH調節剤は、特に制限されないが、通常の医薬品や化粧品に配合される酸や塩基性の化合物を使用することができる。例えば、水酸化ナトリウム、ジイソプロパノールアミン、塩酸、リン酸、乳酸等を挙げることができる。pH調節の際には、これらのpH調節剤を1種又は2種以上を組み合わせて使用することができる。 The pH of the cream of the present invention is preferably adjusted to 4.5-9. The pH regulator is not particularly limited, but an acid or basic compound blended in a normal pharmaceutical or cosmetic can be used. For example, sodium hydroxide, diisopropanolamine, hydrochloric acid, phosphoric acid, lactic acid and the like can be mentioned. In adjusting the pH, these pH adjusting agents can be used alone or in combination of two or more.
本発明のクリーム剤は、通常クリーム剤を調製する際に必要な界面活性剤を配合しなくても安定なクリーム剤を製造することができる。ただし、必要に応じて界面活性剤を配合してもよい。 本発明のクリーム剤においては、上記した成分の他、本発明の効果を損なわない範囲で、通常外用剤に用いられる種々の成分を配合することができる。例えば、賦形剤、育毛成分(6−ベンジルアミノプリン、アデノシン、ペンタデカン酸グリセリド、何首鳥、竹節人参等)、血管拡張剤(塩化カルプロニウム、ニコチン酸ベンジル、センブリ抽出液、オタネニンジンエキス、トウガラシチンキ等)、抗ヒスタミン剤(塩酸ジフェンヒドラミン、塩酸イソチペンジル等)、抗炎症剤(グアイアズレン等)、角質溶解剤(尿素、サリチル酸等)、殺菌剤(グルコン酸クロルヘキシジン、イソプロピルメチルフェノール、第4級アンモニウム塩、ピロクトンオラミン等)、保湿剤(ヒアルロン酸又はその塩、コンドロイチン硫酸等)、各種動植物(イチイ、ボタンピ、カンゾウ、オトギリソウ、附子、ビワ、カワラヨモギ、コンフリー、アシタバ、サフラン、サンシシ、ローズマリー、セージ、モッコウ、セイモッコウ、ホップ、プラセンタ等)の抽出物、ビタミン類(酢酸レチノール、アスコルビン酸、硝酸チアミン、シアノコバラミン、ビオチン等)、抗酸化剤(ジブチルヒドロキシトルエン、ピロ亜硫酸ナトリウム、トコフェロール、エデト酸ナトリウム、アスコルビン酸、イソプロピルガレート等)、溶解補助剤(アジピン酸ジイソプロピル、ミリスチン酸イソプロピル、各種植物油、各種動物油、炭化水素類等)、代謝賦活剤(パンテノール等)、粘着剤、香料、清涼化剤(ハッカ油、カンフル等)及び染料等の通常使用される成分を配合することができる。 The cream of the present invention can produce a stable cream without adding a surfactant that is usually required when preparing the cream. However, you may mix | blend surfactant as needed. In the cream of the present invention, in addition to the above-described components, various components that are usually used in external preparations can be blended within a range that does not impair the effects of the present invention. For example, excipients, hair-growth ingredients (6-benzylaminopurine, adenosine, pentadecanoic acid glyceride, garlic, bamboo ginseng, etc.), vasodilators (carpronium chloride, benzyl nicotinate, assembly extract, ginseng extract, chili pepper tincture) Etc.), antihistamines (diphenhydramine hydrochloride, isothipentyl hydrochloride, etc.), anti-inflammatory agents (guaiazulene, etc.), keratolytic agents (urea, salicylic acid, etc.), bactericides (chlorhexidine gluconate, isopropylmethylphenol, quaternary ammonium salt, piroctone) Olamine, etc.), moisturizers (hyaluronic acid or salts thereof, chondroitin sulfate, etc.), various animals and plants (yew, buttonpi, licorice, hypericum, appendix, loquat, sagebrush, comfrey, ashitaba, saffron, sanshishi, rosemary, sage, Mo Extracts of Kou, Seimo, Hop, Placenta, etc., Vitamins (Retinol acetate, Ascorbic acid, Thiamine nitrate, Cyanocobalamin, Biotin, etc.), Antioxidants (Dibutylhydroxytoluene, Sodium pyrosulfite, Tocopherol, Sodium edetate, Ascorbine Acid, isopropyl gallate, etc.), solubilizers (diisopropyl adipate, isopropyl myristate, various vegetable oils, various animal oils, hydrocarbons, etc.), metabolic activators (pantenol, etc.), adhesives, fragrances, cooling agents (mint) Oil, camphor, etc.) and commonly used ingredients such as dyes can be blended.
本発明のクリーム剤の調製は、常法に従い、上記各成分を含有することにより調製される。 The cream of the present invention is prepared by containing each of the above components according to a conventional method.
かくして得られる本発明のクリーム剤は、頭髪用剤、皮膚適用製剤等として使用することができる。 The cream of the present invention thus obtained can be used as a hair preparation, a preparation for skin application and the like.
以下に、実施例、比較例及び試験例を記載し、本発明をさらに具体的に説明するが、本発明はこれら実施例等により何ら制約されるものではない。また、カルボキシビニルポリマーはLUBRIZOL社製のカーボポール980を用い、部分けん化ポリビニルアルコールは日本合成化学工業社製のゴーセノールEG−05(けん化度86.5〜89.0mol%)を用いた。 EXAMPLES Examples, comparative examples, and test examples will be described below, and the present invention will be described more specifically. However, the present invention is not limited by these examples. In addition, Carbopol 980 manufactured by LUBRIZOL was used as the carboxyvinyl polymer, and Gohsenol EG-05 (saponification degree: 86.5-89.0 mol%) manufactured by Nippon Synthetic Chemical Industry was used as the partially saponified polyvinyl alcohol.
(実施例1)
ミノキシジル 1g
イソステアリン酸 3g
カルボキシビニルポリマー 0.75g
部分けん化ポリビニルアルコール 1g
1,3−ブチレングリコール 15g
水酸化ナトリウム水溶液 適量
精製水 全100g
カルボキシビニルポリマー0.75gを精製水50gに分散し、約50℃まで加温して水溶液を得た。更に部分けん化ポリビニルアルコール1gを約50℃に加温した精製水10gに溶解して水溶液を得た。2つの水溶液を合わせ、これに水酸化ナトリウム水溶液(適量)を加え水相とした。別にイソステアリン酸3gと1,3−ブチレングリコール15gの混合物を約70℃に加温し、これにミノキシジル1gを溶解して油相とした。水相に油相を添加し、更に残りの精製水を加え、均一になるまで攪拌した後、攪拌しながら室温まで冷却しpH7.0の製剤を得た。
Example 1
Minoxidil 1g
Isostearic acid 3g
Carboxy vinyl polymer 0.75g
1g partially saponified polyvinyl alcohol
1,3-butylene glycol 15g
Sodium hydroxide aqueous solution 100g of purified water
0.75 g of carboxyvinyl polymer was dispersed in 50 g of purified water and heated to about 50 ° C. to obtain an aqueous solution. Further, 1 g of partially saponified polyvinyl alcohol was dissolved in 10 g of purified water heated to about 50 ° C. to obtain an aqueous solution. Two aqueous solutions were combined, and an aqueous sodium hydroxide solution (appropriate amount) was added to form an aqueous phase. Separately, a mixture of 3 g of isostearic acid and 15 g of 1,3-butylene glycol was heated to about 70 ° C., and 1 g of minoxidil was dissolved therein to obtain an oil phase. The oil phase was added to the aqueous phase, the remaining purified water was further added, and the mixture was stirred until uniform, and then cooled to room temperature with stirring to obtain a preparation having a pH of 7.0.
(実施例2)
ミノキシジル 1g
イソステアリン酸 6g
カルボキシビニルポリマー 0.5g
部分けん化ポリビニルアルコール 1g
ジイソプロパノールアミン 適量
精製水 全100g
カルボキシビニルポリマー0.5gを精製水50gに分散し、約50℃まで加温して水溶液を得た。更に部分けん化ポリビニルアルコール1gを約50℃に加温した精製水10gに溶解して水溶液を得た。2つの水溶液を合わせ水相とした。別にイソステアリン酸6gとジイソプロパノールアミンの混合物を約70℃に加温し、これにミノキシジル1gを溶解して油相とした。水相に油相を添加し、更に残りの精製水を加え、均一になるまで攪拌した後、攪拌しながら室温まで冷却しpH5.2の製剤を得た。
(Example 2)
Minoxidil 1g
6g of isostearic acid
Carboxy vinyl polymer 0.5g
1g partially saponified polyvinyl alcohol
Diisopropanolamine appropriate amount purified water 100g
Carboxyvinyl polymer 0.5g was disperse | distributed to purified water 50g, and it heated to about 50 degreeC, and obtained aqueous solution. Further, 1 g of partially saponified polyvinyl alcohol was dissolved in 10 g of purified water heated to about 50 ° C. to obtain an aqueous solution. The two aqueous solutions were combined into an aqueous phase. Separately, a mixture of 6 g of isostearic acid and diisopropanolamine was heated to about 70 ° C., and 1 g of minoxidil was dissolved therein to obtain an oil phase. The oil phase was added to the aqueous phase, the remaining purified water was further added, and the mixture was stirred until uniform, and then cooled to room temperature with stirring to obtain a formulation having a pH of 5.2.
(実施例3)
ミノキシジル 2g
イソステアリン酸 10g
カルボキシビニルポリマー 0.8g
部分けん化ポリビニルアルコール 1.2g
1,3−ブチレングリコール 10g
ジイソプロパノールアミン 適量
精製水 全100g
カルボキシビニルポリマー0.8gを精製水50gに分散し、約50℃まで加温して水溶液を得た。更に部分けん化ポリビニルアルコール1.2gを約50℃に加温した精製水10gに溶解して水溶液を得た。2つの水溶液を合わせ水相とした。別にイソステアリン酸10g、1,3−ブチレングリコール10g、ジイソプロパノールアミンの混合物を約70℃に加温し、これにミノキシジル2gを溶解して油相とした。水相に油相を添加し、更に残りの精製水を加え、均一になるまで攪拌した後、攪拌しながら室温まで冷却しpH5.4の製剤を得た。
(Example 3)
Minoxidil 2g
10g of isostearic acid
Carboxy vinyl polymer 0.8g
Partially saponified polyvinyl alcohol 1.2g
1,3-butylene glycol 10g
Diisopropanolamine appropriate amount purified water 100g
Carboxyvinyl polymer 0.8g was disperse | distributed to purified water 50g, and it heated to about 50 degreeC, and obtained aqueous solution. Further, 1.2 g of partially saponified polyvinyl alcohol was dissolved in 10 g of purified water heated to about 50 ° C. to obtain an aqueous solution. The two aqueous solutions were combined into an aqueous phase. Separately, a mixture of 10 g of isostearic acid, 10 g of 1,3-butylene glycol and diisopropanolamine was heated to about 70 ° C., and 2 g of minoxidil was dissolved therein to obtain an oil phase. The oil phase was added to the aqueous phase, the remaining purified water was further added, and the mixture was stirred until it became homogeneous, and then cooled to room temperature with stirring to obtain a formulation having a pH of 5.4.
(実施例4)
ミノキシジル 1g
イソステアリン酸 10g
カルボキシビニルポリマー 0.8g
部分けん化ポリビニルアルコール 1.2g
モノオレイン酸ポリオキシエチレンソルビタン 5g
(20E.O.)
ジイソプロパノールアミン 適量
精製水 全100g
カルボキシビニルポリマー0.8gを精製水50gに分散し、約50℃まで加温して水溶液を得た。更に部分けん化ポリビニルアルコール1.2gを約50℃に加温した精製水10gに溶解して水溶液を得た。2つの水溶液を合わせ水相とした。別にイソステアリン酸10g、モノオレイン酸ポリオキシエチレンソルビタン(20E.O.)5g、ジイソプロパノールアミンの混合物を約70℃に加温し、これにミノキシジル1gを溶解して油相とした。水相に油相を添加し、更に残りの精製水を加え、均一になるまで攪拌した後、攪拌しながら室温まで冷却しpH4.9の製剤を得た。
Example 4
Minoxidil 1g
10g of isostearic acid
Carboxy vinyl polymer 0.8g
Partially saponified polyvinyl alcohol 1.2g
5g polyoxyethylene sorbitan monooleate
(20 EO)
Diisopropanolamine appropriate amount purified water 100g
Carboxyvinyl polymer 0.8g was disperse | distributed to purified water 50g, and it heated to about 50 degreeC, and obtained aqueous solution. Further, 1.2 g of partially saponified polyvinyl alcohol was dissolved in 10 g of purified water heated to about 50 ° C. to obtain an aqueous solution. The two aqueous solutions were combined into an aqueous phase. Separately, a mixture of 10 g of isostearic acid, 5 g of polyoxyethylene sorbitan monooleate (20E.O.), and diisopropanolamine was heated to about 70 ° C., and 1 g of minoxidil was dissolved therein to obtain an oil phase. The oil phase was added to the aqueous phase, the remaining purified water was further added, and the mixture was stirred until it was homogeneous, and then cooled to room temperature with stirring to obtain a preparation having a pH of 4.9.
(実施例5)
ミノキシジル 1g
イソステアリン酸 10g
カルボキシビニルポリマー 0.8g
部分けん化ポリビニルアルコール 1g
モノステアリン酸ポリエチレングリコール 5g
(40E.O.)
ジイソプロパノールアミン 適量
精製水 全100g
カルボキシビニルポリマー0.8gを精製水50gに分散し、約50℃まで加温して水溶液を得た。更に部分けん化ポリビニルアルコール1gを約50℃に加温した精製水10gに溶解して水溶液を得た。2つの水溶液を合わせ水相とした。別にイソステアリン酸10g、モノステアリン酸ポリエチレングリコール(40E.O.)5g、ジイソプロパノールアミンの混合物を約70℃に加温し、これにミノキシジル1gを溶解して油相とした。水相に油相を添加し、更に残りの精製水を加え、均一になるまで攪拌した後、攪拌しながら室温まで冷却しpH6.1の製剤を得た。
(Example 5)
Minoxidil 1g
10g of isostearic acid
Carboxy vinyl polymer 0.8g
1g partially saponified polyvinyl alcohol
Polyethylene glycol monostearate 5g
(40E.O.)
Diisopropanolamine appropriate amount purified water 100g
Carboxyvinyl polymer 0.8g was disperse | distributed to purified water 50g, and it heated to about 50 degreeC, and obtained aqueous solution. Further, 1 g of partially saponified polyvinyl alcohol was dissolved in 10 g of purified water heated to about 50 ° C. to obtain an aqueous solution. The two aqueous solutions were combined into an aqueous phase. Separately, a mixture of 10 g of isostearic acid, 5 g of polyethylene glycol monostearate (40E.O.), and diisopropanolamine was heated to about 70 ° C., and 1 g of minoxidil was dissolved therein to obtain an oil phase. The oil phase was added to the aqueous phase, the remaining purified water was further added, and the mixture was stirred until it was uniform, and then cooled to room temperature with stirring to obtain a formulation having a pH of 6.1.
(実施例6)
ミノキシジル 1g
イソステアリン酸 10g
カルボキシビニルポリマー 0.8g
部分けん化ポリビニルアルコール 1g
モノステアリン酸ポリオキシエチレンソルビタン 5g
モノステアリン酸ソルビタン 5g
ジイソプロパノールアミン 適量
精製水 全100g
カルボキシビニルポリマー0.8gを精製水50gに分散し、約50℃まで加温して水溶液を得た。更に部分けん化ポリビニルアルコール1gを約50℃に加温した精製水10gに溶解して水溶液を得た。2つの水溶液を合わせ水相とした。別にイソステアリン酸10g、モノステアリン酸ポリオキシエチレンソルビタン5g、モノステアリン酸ソルビタン5g、ジイソプロパノールアミンの混合物を約70℃に加温し、これにミノキシジル1gを溶解して油相とした。水相に油相を添加し、更に残りの精製水を加え、均一になるまで攪拌した後、攪拌しながら室温まで冷却しpH6.0の製剤を得た。
(Example 6)
Minoxidil 1g
10g of isostearic acid
Carboxy vinyl polymer 0.8g
1g partially saponified polyvinyl alcohol
5 g polyoxyethylene sorbitan monostearate
5g sorbitan monostearate
Diisopropanolamine appropriate amount purified water 100g
Carboxyvinyl polymer 0.8g was disperse | distributed to purified water 50g, and it heated to about 50 degreeC, and obtained aqueous solution. Further, 1 g of partially saponified polyvinyl alcohol was dissolved in 10 g of purified water heated to about 50 ° C. to obtain an aqueous solution. The two aqueous solutions were combined into an aqueous phase. Separately, a mixture of 10 g of isostearic acid, 5 g of polyoxyethylene sorbitan monostearate, 5 g of sorbitan monostearate, and diisopropanolamine was heated to about 70 ° C., and 1 g of minoxidil was dissolved therein to obtain an oil phase. The oil phase was added to the aqueous phase, the remaining purified water was further added, and the mixture was stirred until uniform, and then cooled to room temperature with stirring to obtain a pH 6.0 formulation.
(実施例7)
ミノキシジル 1g
イソステアリン酸 6g
カルボキシビニルポリマー 0.5g
部分けん化ポリビニルアルコール 1g
1,3−ブチレングリコール 10g
ジイソプロパノールアミン 適量
精製水 全100g
カルボキシビニルポリマー0.5gを精製水50gに分散し、約50℃まで加温して水溶液を得た。更に部分けん化ポリビニルアルコール1gを約50℃に加温した精製水10gに溶解して水溶液を得た。2つの水溶液を合わせ水相とした。別にイソステアリン酸6g、1,3−ブチレングリコール10g、ジイソプロパノールアミンの混合物を約70℃に加温し、これにミノキシジル1gを溶解して油相とした。水相に油相を添加し、更に残りの精製水を加え、均一になるまで攪拌した後、攪拌しながら室温まで冷却しpH5.6の製剤を得た。
(Example 7)
Minoxidil 1g
6g of isostearic acid
Carboxy vinyl polymer 0.5g
1g partially saponified polyvinyl alcohol
1,3-butylene glycol 10g
Diisopropanolamine appropriate amount purified water 100g
Carboxyvinyl polymer 0.5g was disperse | distributed to purified water 50g, and it heated to about 50 degreeC, and obtained aqueous solution. Further, 1 g of partially saponified polyvinyl alcohol was dissolved in 10 g of purified water heated to about 50 ° C. to obtain an aqueous solution. The two aqueous solutions were combined into an aqueous phase. Separately, a mixture of 6 g of isostearic acid, 10 g of 1,3-butylene glycol and diisopropanolamine was heated to about 70 ° C., and 1 g of minoxidil was dissolved therein to obtain an oil phase. The oil phase was added to the aqueous phase, the remaining purified water was further added, and the mixture was stirred until it became homogeneous, and then cooled to room temperature with stirring to obtain a preparation having a pH of 5.6.
(実施例8)
ミノキシジル 1g
イソステアリン酸 6g
カルボキシビニルポリマー 0.5g
部分けん化ポリビニルアルコール 1g
ジプロピレングリコール 10g
ジイソプロパノールアミン 適量
精製水 全100g
カルボキシビニルポリマー0.5gを精製水50gに分散し、約50℃まで加温して水溶液を得た。更に部分けん化ポリビニルアルコール1gを約50℃に加温した精製水10gに溶解して水溶液を得た。2つの水溶液を合わせ水相とした。別にイソステアリン酸6g、ジプロピレングリコール10g、ジイソプロパノールアミンの混合物を約70℃に加温し、これにミノキシジル1gを溶解して油相とした。水相に油相を添加し、更に残りの精製水を加え、均一になるまで攪拌した後、攪拌しながら室温まで冷却しpH5.5の製剤を得た。
(Example 8)
Minoxidil 1g
6g of isostearic acid
Carboxy vinyl polymer 0.5g
1g partially saponified polyvinyl alcohol
Dipropylene glycol 10g
Diisopropanolamine appropriate amount purified water 100g
Carboxyvinyl polymer 0.5g was disperse | distributed to purified water 50g, and it heated to about 50 degreeC, and obtained aqueous solution. Further, 1 g of partially saponified polyvinyl alcohol was dissolved in 10 g of purified water heated to about 50 ° C. to obtain an aqueous solution. The two aqueous solutions were combined into an aqueous phase. Separately, a mixture of 6 g of isostearic acid, 10 g of dipropylene glycol and diisopropanolamine was heated to about 70 ° C., and 1 g of minoxidil was dissolved therein to obtain an oil phase. The oil phase was added to the aqueous phase, the remaining purified water was further added, and the mixture was stirred until it was uniform, and then cooled to room temperature with stirring to obtain a formulation having a pH of 5.5.
(実施例9)
ミノキシジル 1g
イソステアリン酸 6g
カルボキシビニルポリマー 0.5g
部分けん化ポリビニルアルコール 1g
グリセリン 10g
ジイソプロパノールアミン 適量
精製水 全100g
カルボキシビニルポリマー0.5gを精製水50gに分散し、約50℃まで加温して水溶液を得た。更に部分けん化ポリビニルアルコール1gを約50℃に加温した精製水10gに溶解して水溶液を得た。2つの水溶液を合わせ水相とした。別にイソステアリン酸6g、グリセリン10g、ジイソプロパノールアミンの混合物を約70℃に加温し、これにミノキシジル1gを溶解して油相とした。水相に油相を添加し、更に残りの精製水を加え、均一になるまで攪拌した後、攪拌しながら室温まで冷却しpH5.5の製剤を得た。
Example 9
Minoxidil 1g
6g of isostearic acid
Carboxy vinyl polymer 0.5g
1g partially saponified polyvinyl alcohol
Glycerin 10g
Diisopropanolamine appropriate amount purified water 100g
Carboxyvinyl polymer 0.5g was disperse | distributed to purified water 50g, and it heated to about 50 degreeC, and obtained aqueous solution. Further, 1 g of partially saponified polyvinyl alcohol was dissolved in 10 g of purified water heated to about 50 ° C. to obtain an aqueous solution. The two aqueous solutions were combined into an aqueous phase. Separately, a mixture of 6 g of isostearic acid, 10 g of glycerin and diisopropanolamine was heated to about 70 ° C., and 1 g of minoxidil was dissolved therein to obtain an oil phase. The oil phase was added to the aqueous phase, the remaining purified water was further added, and the mixture was stirred until it was uniform, and then cooled to room temperature with stirring to obtain a formulation having a pH of 5.5.
(実施例10)
ミノキシジル 1g
イソステアリン酸 6g
カルボキシビニルポリマー 0.5g
部分けん化ポリビニルアルコール 1g
プロピレングリコール 10g
ジイソプロパノールアミン 適量
精製水 全100g
カルボキシビニルポリマー0.5gを精製水50gに分散し、約50℃まで加温して水溶液を得た。更に部分けん化ポリビニルアルコール1gを約50℃に加温した精製水10gに溶解して水溶液を得た。2つの水溶液を合わせ水相とした。別にイソステアリン酸6g、プロピレングリコール10g、ジイソプロパノールアミンの混合物を約70℃に加温し、これにミノキシジル1gを溶解して油相とした。水相に油相を添加し、更に残りの精製水を加え、均一になるまで攪拌した後、攪拌しながら室温まで冷却しpH5.6の製剤を得た。
(Example 10)
Minoxidil 1g
6g of isostearic acid
Carboxy vinyl polymer 0.5g
1g partially saponified polyvinyl alcohol
10g of propylene glycol
Diisopropanolamine appropriate amount purified water 100g
Carboxyvinyl polymer 0.5g was disperse | distributed to purified water 50g, and it heated to about 50 degreeC, and obtained aqueous solution. Further, 1 g of partially saponified polyvinyl alcohol was dissolved in 10 g of purified water heated to about 50 ° C. to obtain an aqueous solution. The two aqueous solutions were combined into an aqueous phase. Separately, a mixture of 6 g of isostearic acid, 10 g of propylene glycol and diisopropanolamine was heated to about 70 ° C., and 1 g of minoxidil was dissolved therein to obtain an oil phase. The oil phase was added to the aqueous phase, the remaining purified water was further added, and the mixture was stirred until it became homogeneous, and then cooled to room temperature with stirring to obtain a preparation with pH 5.6.
(実施例11)
ミノキシジル 1g
イソステアリン酸 10g
カルボキシビニルポリマー 0.8g
部分けん化ポリビニルアルコール 1.2g
水酸化ナトリウム水溶液 適量
精製水 全100g
カルボキシビニルポリマー0.8gを精製水50gに分散し、約50℃まで加温して水溶液を得た。更に部分けん化ポリビニルアルコール1.2gを約50℃に加温した精製水10gに溶解して水溶液を得た。2つの水溶液を合わせ、これに水酸化ナトリウム水溶液(適量)を加え水相とした。別にイソステアリン酸10gを約70℃に加温し、これにミノキシジル1gを溶解して油相とした。水相に油相を添加し、更に残りの精製水を加え、均一になるまで攪拌した後、攪拌しながら室温まで冷却しpH6.4の製剤を得た。
(Example 11)
Minoxidil 1g
10g of isostearic acid
Carboxy vinyl polymer 0.8g
Partially saponified polyvinyl alcohol 1.2g
Sodium hydroxide aqueous solution 100g of purified water
Carboxyvinyl polymer 0.8g was disperse | distributed to purified water 50g, and it heated to about 50 degreeC, and obtained aqueous solution. Further, 1.2 g of partially saponified polyvinyl alcohol was dissolved in 10 g of purified water heated to about 50 ° C. to obtain an aqueous solution. Two aqueous solutions were combined, and an aqueous sodium hydroxide solution (appropriate amount) was added to form an aqueous phase. Separately, 10 g of isostearic acid was heated to about 70 ° C., and 1 g of minoxidil was dissolved therein to obtain an oil phase. The oil phase was added to the aqueous phase, the remaining purified water was further added, and the mixture was stirred until uniform, and then cooled to room temperature with stirring to obtain a pH 6.4 preparation.
(実施例12)
ミノキシジル 1g
オレイン酸 10g
カルボキシビニルポリマー 0.8g
部分けん化ポリビニルアルコール 1.2g
水酸化ナトリウム水溶液 適量
精製水 全100g
カルボキシビニルポリマー0.8gを精製水50gに分散し、約50℃まで加温して水溶液を得た。更に部分けん化ポリビニルアルコール1.2gを約50℃に加温した精製水10gに溶解して水溶液を得た。2つの水溶液を合わせ,これに水酸化ナトリウム水溶液(適量)を加え水相とした。別にオレイン酸10gを約70℃に加温し、これにミノキシジル1gを溶解して油相とした。水相に油相を添加し、更に残りの精製水を加え、均一になるまで攪拌した後、攪拌しながら室温まで冷却しpH6.4の製剤を得た。
Example 12
Minoxidil 1g
Oleic acid 10g
Carboxy vinyl polymer 0.8g
Partially saponified polyvinyl alcohol 1.2g
Sodium hydroxide aqueous solution 100g of purified water
Carboxyvinyl polymer 0.8g was disperse | distributed to purified water 50g, and it heated to about 50 degreeC, and obtained aqueous solution. Further, 1.2 g of partially saponified polyvinyl alcohol was dissolved in 10 g of purified water heated to about 50 ° C. to obtain an aqueous solution. The two aqueous solutions were combined, and an aqueous sodium hydroxide solution (appropriate amount) was added to form an aqueous phase. Separately, 10 g of oleic acid was heated to about 70 ° C., and 1 g of minoxidil was dissolved therein to obtain an oil phase. The oil phase was added to the aqueous phase, the remaining purified water was further added, and the mixture was stirred until uniform, and then cooled to room temperature with stirring to obtain a pH 6.4 preparation.
(実施例13)
ミノキシジル 1g
イソステアリン酸 10g
カルボキシビニルポリマー 0.1g
部分けん化ポリビニルアルコール 0.1g
水酸化ナトリウム水溶液 適量
エタノール 5g
精製水 全100g
カルボキシビニルポリマー0.1gを精製水50gに分散し、約50℃まで加温して水溶液を得た。更に部分けん化ポリビニルアルコール0.1gを約50℃に加温した精製水10gに溶解して水溶液を得た。2つの水溶液を合わせ、これに水酸化ナトリウム水溶液(適量)を加え水相とした。別にイソステアリン酸10gを約70℃に加温し、これにミノキシジル1gを溶解して油相とした。水相に油相を添加し、更に残りの精製水を加え、均一になるまで攪拌した後、攪拌しながら室温まで冷却した。これにエタノール5gを加え撹拌しpH6.0の製剤を得た。
(実施例14)
ミノキシジル 1g
イソステアリン酸 6g
カルボキシビニルポリマー 0.75g
部分けん化ポリビニルアルコール 1g
1,3−ブチレングリコール 10g
水酸化ナトリウム水溶液 適量
精製水 全100g
カルボキシビニルポリマー0.75gを精製水50gに分散し、約50℃まで加温して水溶液を得た。更に部分けん化ポリビニルアルコール1gを約50℃に加温した精製水10gに溶解して水溶液を得た。2つの水溶液を合わせ、これに水酸化ナトリウム水溶液(適量)を加え水相とした。別にイソステアリン酸6gと1,3−ブチレングリコール10gの混合物を約70℃に加温し、これにミノキシジル1gを溶解して油相とした。水相に油相を添加し、更に残りの精製水を加え、均一になるまで攪拌した後、攪拌しながら室温まで冷却しpH8.7の製剤を得た。
(Example 13)
Minoxidil 1g
10g of isostearic acid
Carboxyvinyl polymer 0.1g
0.1g of partially saponified polyvinyl alcohol
Sodium hydroxide aqueous solution appropriate amount ethanol 5g
100g of purified water
0.1 g of carboxyvinyl polymer was dispersed in 50 g of purified water and heated to about 50 ° C. to obtain an aqueous solution. Further, 0.1 g of partially saponified polyvinyl alcohol was dissolved in 10 g of purified water heated to about 50 ° C. to obtain an aqueous solution. Two aqueous solutions were combined, and an aqueous sodium hydroxide solution (appropriate amount) was added to form an aqueous phase. Separately, 10 g of isostearic acid was heated to about 70 ° C., and 1 g of minoxidil was dissolved therein to obtain an oil phase. The oil phase was added to the aqueous phase, the remaining purified water was further added, and the mixture was stirred until uniform, and then cooled to room temperature while stirring. To this was added 5 g of ethanol and stirred to obtain a preparation having a pH of 6.0.
(Example 14)
Minoxidil 1g
6g of isostearic acid
Carboxy vinyl polymer 0.75g
1g partially saponified polyvinyl alcohol
1,3-butylene glycol 10g
Sodium hydroxide aqueous solution 100g of purified water
0.75 g of carboxyvinyl polymer was dispersed in 50 g of purified water and heated to about 50 ° C. to obtain an aqueous solution. Further, 1 g of partially saponified polyvinyl alcohol was dissolved in 10 g of purified water heated to about 50 ° C. to obtain an aqueous solution. Two aqueous solutions were combined, and an aqueous sodium hydroxide solution (appropriate amount) was added to form an aqueous phase. Separately, a mixture of 6 g of isostearic acid and 10 g of 1,3-butylene glycol was heated to about 70 ° C., and 1 g of minoxidil was dissolved therein to obtain an oil phase. The oil phase was added to the aqueous phase, the remaining purified water was further added, and the mixture was stirred until uniform, and then cooled to room temperature with stirring to obtain a formulation having a pH of 8.7.
(比較例1)
ミノキシジル 1g
トリ(カプリル/カプリン酸)グリセリル 10g
カルボキシビニルポリマー 0.8g
部分けん化ポリビニルアルコール 1.2g
水酸化ナトリウム水溶液 適量
精製水 全100g
カルボキシビニルポリマー0.8gを精製水50gに分散し、約50℃まで加温して水溶液を得た。更に部分けん化ポリビニルアルコール1.2gを約50℃に加温した精製水10gに溶解して水溶液を得た。2つの水溶液を合わせ、これに水酸化ナトリウム水溶液(適量)を加え水相とした。別にトリ(カプリル/カプリン酸)グリセリル10gを約70℃に加温し、これにミノキシジル1gを溶解して油相とした。水相に油相を添加し、更に残りの精製水を加え、均一になるまで攪拌した後、攪拌しながら室温まで冷却しpH6.3の製剤を得た。
(Comparative Example 1)
Minoxidil 1g
Tri (capryl / capric acid) glyceryl 10g
Carboxy vinyl polymer 0.8g
Partially saponified polyvinyl alcohol 1.2g
Sodium hydroxide aqueous solution 100g of purified water
Carboxyvinyl polymer 0.8g was disperse | distributed to purified water 50g, and it heated to about 50 degreeC, and obtained aqueous solution. Further, 1.2 g of partially saponified polyvinyl alcohol was dissolved in 10 g of purified water heated to about 50 ° C. to obtain an aqueous solution. Two aqueous solutions were combined, and an aqueous sodium hydroxide solution (appropriate amount) was added to form an aqueous phase. Separately, 10 g of tri (capryl / capric acid) glyceryl was heated to about 70 ° C., and 1 g of minoxidil was dissolved therein to obtain an oil phase. The oil phase was added to the aqueous phase, the remaining purified water was further added, and the mixture was stirred until uniform, and then cooled to room temperature while stirring to obtain a preparation with pH 6.3.
(比較例2)
ミノキシジル 1g
流動パラフィン 10g
カルボキシビニルポリマー 0.8g
部分けん化ポリビニルアルコール 1.2g
水酸化ナトリウム水溶液 適量
精製水 全100g
カルボキシビニルポリマー0.8gを精製水50gに分散し、約50℃まで加温して水溶液を得た。更に部分けん化ポリビニルアルコール1.2gを約50℃に加温した精製水10gに溶解して水溶液を得た。2つの水溶液を合わせ、これに水酸化ナトリウム水溶液(適量)を加え水相とした。別に流動パラフィン10gを約70℃に加温し、これにミノキシジル1gを溶解して油相とした。水相に油相を添加し、更に残りの精製水を加え、均一になるまで攪拌した後、攪拌しながら室温まで冷却しpH6.5の製剤を得た。
(Comparative Example 2)
Minoxidil 1g
Liquid paraffin 10g
Carboxy vinyl polymer 0.8g
Partially saponified polyvinyl alcohol 1.2g
Sodium hydroxide aqueous solution 100g of purified water
Carboxyvinyl polymer 0.8g was disperse | distributed to purified water 50g, and it heated to about 50 degreeC, and obtained aqueous solution. Further, 1.2 g of partially saponified polyvinyl alcohol was dissolved in 10 g of purified water heated to about 50 ° C. to obtain an aqueous solution. Two aqueous solutions were combined, and an aqueous sodium hydroxide solution (appropriate amount) was added to form an aqueous phase. Separately, 10 g of liquid paraffin was heated to about 70 ° C., and 1 g of minoxidil was dissolved therein to obtain an oil phase. The oil phase was added to the aqueous phase, the remaining purified water was further added, and the mixture was stirred until uniform, and then cooled to room temperature with stirring to obtain a pH 6.5 formulation.
(比較例3)
ミノキシジル 1g
アジピン酸ジイソプロピル 10g
カルボキシビニルポリマー 0.8g
部分けん化ポリビニルアルコール 1.2g
水酸化ナトリウム水溶液 適量
精製水 全100g
カルボキシビニルポリマー0.8gを精製水50gに分散し、約50℃まで加温して水溶液を得た。更に部分けん化ポリビニルアルコール1.2gを約50℃に加温した精製水10gに溶解して水溶液を得た。2つの水溶液を合わせ,これに水酸化ナトリウム水溶液(適量)を加え水相とした。別にアジピン酸ジイソプロピル10gを約70℃に加温し、これにミノキシジル1gを溶解して油相とした。水相に油相を添加し、更に残りの精製水を加え、均一になるまで攪拌した後、攪拌しながら室温まで冷却しpH6.5の製剤を得た。
(Comparative Example 3)
Minoxidil 1g
Diisopropyl adipate 10g
Carboxy vinyl polymer 0.8g
Partially saponified polyvinyl alcohol 1.2g
Sodium hydroxide aqueous solution 100g of purified water
Carboxyvinyl polymer 0.8g was disperse | distributed to purified water 50g, and it heated to about 50 degreeC, and obtained aqueous solution. Further, 1.2 g of partially saponified polyvinyl alcohol was dissolved in 10 g of purified water heated to about 50 ° C. to obtain an aqueous solution. Two aqueous solutions were combined, and an aqueous sodium hydroxide solution (appropriate amount) was added to form an aqueous phase. Separately, 10 g of diisopropyl adipate was heated to about 70 ° C., and 1 g of minoxidil was dissolved therein to obtain an oil phase. The oil phase was added to the aqueous phase, the remaining purified water was further added, and the mixture was stirred until uniform, and then cooled to room temperature with stirring to obtain a pH 6.5 formulation.
(比較例4)
ミノキシジル 1g
ミリスチン酸イソプロピル 10g
カルボキシビニルポリマー 0.8g
部分けん化ポリビニルアルコール 1.2g
水酸化ナトリウム水溶液 適量
精製水 全100g
カルボキシビニルポリマー0.8gを精製水50gに分散し、約50℃まで加温して水溶液を得た。更に部分けん化ポリビニルアルコール1.2gを約50℃に加温した精製水10gに溶解して水溶液を得た。2つの水溶液を合わせ,これに水酸化ナトリウム水溶液(適量)を加え水相とした。別にミリスチン酸イソプロピル10gを約70℃に加温し、これにミノキシジル1gを溶解して油相とした。水相に油相を添加し、更に残りの精製水を加え、均一になるまで攪拌した後、攪拌しながら室温まで冷却しpH6.4の製剤を得た。
(Comparative Example 4)
Minoxidil 1g
10g isopropyl myristate
Carboxy vinyl polymer 0.8g
Partially saponified polyvinyl alcohol 1.2g
Sodium hydroxide aqueous solution 100g of purified water
Carboxyvinyl polymer 0.8g was disperse | distributed to purified water 50g, and it heated to about 50 degreeC, and obtained aqueous solution. Further, 1.2 g of partially saponified polyvinyl alcohol was dissolved in 10 g of purified water heated to about 50 ° C. to obtain an aqueous solution. Two aqueous solutions were combined, and an aqueous sodium hydroxide solution (appropriate amount) was added to form an aqueous phase. Separately, 10 g of isopropyl myristate was heated to about 70 ° C., and 1 g of minoxidil was dissolved therein to obtain an oil phase. The oil phase was added to the aqueous phase, the remaining purified water was further added, and the mixture was stirred until uniform, and then cooled to room temperature with stirring to obtain a pH 6.4 preparation.
(比較例5)
ミノキシジル 1g
トリ2−エチルヘキサン酸グリセリル 10g
カルボキシビニルポリマー 0.8g
部分けん化ポリビニルアルコール 1.2g
水酸化ナトリウム水溶液 適量
精製水 全100g
カルボキシビニルポリマー0.8gを精製水50gに分散し、約50℃まで加温して水溶液を得た。更に部分けん化ポリビニルアルコール1.2gを約50℃に加温した精製水10gに溶解して水溶液を得た。2つの水溶液を合わせ,これに水酸化ナトリウム水溶液(適量)を加え水相とした。別にトリ2−エチルヘキサン酸グリセリル10gを約70℃に加温し、これにミノキシジル1gを溶解して油相とした。水相に油相を添加し、更に残りの精製水を加え、均一になるまで攪拌した後、攪拌しながら室温まで冷却しpH6.5の製剤を得た。
(Comparative Example 5)
Minoxidil 1g
10g glyceryl tri-2-ethylhexanoate
Carboxy vinyl polymer 0.8g
Partially saponified polyvinyl alcohol 1.2g
Sodium hydroxide aqueous solution 100g of purified water
Carboxyvinyl polymer 0.8g was disperse | distributed to purified water 50g, and it heated to about 50 degreeC, and obtained aqueous solution. Further, 1.2 g of partially saponified polyvinyl alcohol was dissolved in 10 g of purified water heated to about 50 ° C. to obtain an aqueous solution. Two aqueous solutions were combined, and an aqueous sodium hydroxide solution (appropriate amount) was added to form an aqueous phase. Separately, 10 g of glyceryl tri-2-ethylhexanoate was heated to about 70 ° C., and 1 g of minoxidil was dissolved therein to obtain an oil phase. The oil phase was added to the aqueous phase, the remaining purified water was further added, and the mixture was stirred until uniform, and then cooled to room temperature with stirring to obtain a pH 6.5 formulation.
(比較例6)
ミノキシジル 1g
イソステアリン酸 10g
カルボキシビニルポリマー 0.1g
部分けん化ポリビニルアルコール 0.1g
水酸化ナトリウム水溶液 適量
エタノール 10g
精製水 全100g
カルボキシビニルポリマー0.1gを精製水50gに分散し、約50℃まで加温して水溶液を得た。更に部分けん化ポリビニルアルコール0.1gを約50℃に加温した精製水10gに溶解して水溶液を得た。2つの水溶液を合わせ,これに水酸化ナトリウム水溶液(適量)を加え水相とした。別にイソステアリン酸10gを約70℃に加温し、これにミノキシジル1gを溶解して油相とした。水相に油相を添加し、更に残りの精製水を加え、均一になるまで攪拌した後、攪拌しながら室温まで冷却した。これにエタノール10gを加え撹拌しpH6.2の製剤を得た。
(Comparative Example 6)
Minoxidil 1g
10g of isostearic acid
Carboxyvinyl polymer 0.1g
0.1g of partially saponified polyvinyl alcohol
Sodium hydroxide aqueous solution 10g ethanol 10g
100g of purified water
0.1 g of carboxyvinyl polymer was dispersed in 50 g of purified water and heated to about 50 ° C. to obtain an aqueous solution. Further, 0.1 g of partially saponified polyvinyl alcohol was dissolved in 10 g of purified water heated to about 50 ° C. to obtain an aqueous solution. Two aqueous solutions were combined, and an aqueous sodium hydroxide solution (appropriate amount) was added to form an aqueous phase. Separately, 10 g of isostearic acid was heated to about 70 ° C., and 1 g of minoxidil was dissolved therein to obtain an oil phase. The oil phase was added to the aqueous phase, the remaining purified water was further added, and the mixture was stirred until uniform, and then cooled to room temperature while stirring. To this, 10 g of ethanol was added and stirred to obtain a preparation with pH 6.2.
(比較例7)
ミノキシジル 1g
イソステアリン酸 10g
カルボキシビニルポリマー 0.1g
部分けん化ポリビニルアルコール 0.1g
水酸化ナトリウム水溶液 適量
エタノール 15g
精製水 全100g
カルボキシビニルポリマー0.1gを精製水50gに分散し、約50℃まで加温して水溶液を得た。更に部分けん化ポリビニルアルコール0.1gを約50℃に加温した精製水10gに溶解して水溶液を得た。2つの水溶液を合わせ,これに水酸化ナトリウム水溶液(適量)を加え水相とした。別にイソステアリン酸10gを約70℃に加温し、これにミノキシジル1gを溶解して油相とした。水相に油相を添加し、更に残りの精製水を加え、均一になるまで攪拌した後、攪拌しながら室温まで冷却した。これにエタノール15gを加え撹拌しpH6.3の製剤を得た。
(Comparative Example 7)
Minoxidil 1g
10g of isostearic acid
Carboxyvinyl polymer 0.1g
0.1g of partially saponified polyvinyl alcohol
Sodium hydroxide aqueous solution 15g ethanol
100g of purified water
0.1 g of carboxyvinyl polymer was dispersed in 50 g of purified water and heated to about 50 ° C. to obtain an aqueous solution. Further, 0.1 g of partially saponified polyvinyl alcohol was dissolved in 10 g of purified water heated to about 50 ° C. to obtain an aqueous solution. Two aqueous solutions were combined, and an aqueous sodium hydroxide solution (appropriate amount) was added to form an aqueous phase. Separately, 10 g of isostearic acid was heated to about 70 ° C., and 1 g of minoxidil was dissolved therein to obtain an oil phase. The oil phase was added to the aqueous phase, the remaining purified water was further added, and the mixture was stirred until uniform, and then cooled to room temperature while stirring. To this was added 15 g of ethanol and stirred to obtain a preparation with pH 6.3.
(比較例8)
ミノキシジル 1g
イソステアリン酸 10g
カルボキシビニルポリマー 0.1g
部分けん化ポリビニルアルコール 0.1g
水酸化ナトリウム水溶液 適量
エタノール 20g
精製水 全100g
カルボキシビニルポリマー0.1gを精製水50gに分散し、約50℃まで加温して水溶液を得た。更に部分けん化ポリビニルアルコール0.1gを約50℃に加温した精製水10gに溶解して水溶液を得た。2つの水溶液を合わせ,これに水酸化ナトリウム水溶液(適量)を加え水相とした。別にイソステアリン酸10gを約70℃に加温し、これにミノキシジル1gを溶解して油相とした。水相に油相を添加し、更に残りの精製水を加え、均一になるまで攪拌した後、攪拌しながら室温まで冷却した。これにエタノール20gを加え撹拌しpH6.5の製剤を得た。
(Comparative Example 8)
Minoxidil 1g
10g of isostearic acid
Carboxyvinyl polymer 0.1g
0.1g of partially saponified polyvinyl alcohol
Sodium hydroxide aqueous solution 20g ethanol
100g of purified water
0.1 g of carboxyvinyl polymer was dispersed in 50 g of purified water and heated to about 50 ° C. to obtain an aqueous solution. Further, 0.1 g of partially saponified polyvinyl alcohol was dissolved in 10 g of purified water heated to about 50 ° C. to obtain an aqueous solution. Two aqueous solutions were combined, and an aqueous sodium hydroxide solution (appropriate amount) was added to form an aqueous phase. Separately, 10 g of isostearic acid was heated to about 70 ° C., and 1 g of minoxidil was dissolved therein to obtain an oil phase. The oil phase was added to the aqueous phase, the remaining purified water was further added, and the mixture was stirred until uniform, and then cooled to room temperature while stirring. To this was added 20 g of ethanol and stirred to obtain a preparation with pH 6.5.
試験例1 製剤の使用感
実施例1〜14、比較例1〜5を適量腕に塗布し、ざらつき、しっとり感を評価した。ざらつきのないものを○、あるものを×、しっとり感を強く感じるものを◎、感じるものを○、感じないものを×とした。結果を表1〜3に示す。
Test Example 1 Usability of the preparations Examples 1 to 14 and Comparative Examples 1 to 5 were applied in appropriate amounts to the arms, and the roughness and moist feeling were evaluated. A rough texture was rated as ◯, a certain texture as x, a moist feeling as ◎, a feeling as ○, and a feeling as x. The results are shown in Tables 1-3.
表1〜3の結果から、本発明のイソステアリン酸またはオレイン酸を含有するクリーム剤は使用感が良かった。一方、イソステアリン酸またはオレイン酸以外の油を含有するミノキシジル含有クリーム剤(比較例1〜5)は、皮膚に塗布した際にざらつき等が生じ、使用感が悪かった。これは、製剤中でミノキシジルが十分溶解できず、分散状態となっているためである。 From the results of Tables 1 to 3, the cream preparation containing the isostearic acid or oleic acid of the present invention was good in use feeling. On the other hand, the minoxidil-containing creams containing oils other than isostearic acid or oleic acid (Comparative Examples 1 to 5) were rough when applied to the skin, and the usability was poor. This is because minoxidil cannot be sufficiently dissolved in the preparation and is in a dispersed state.
試験例2 製剤の安定性
実施例1〜14、比較例6〜8を65℃条件下2週経過後の性状を確認した。分離が生じていないものを○、分離が生じているものを×とした。結果を表4〜6に示す。
Test Example 2 Preparation Stability Properties of Examples 1 to 14 and Comparative Examples 6 to 8 were confirmed after 2 weeks passed at 65 ° C. The case where separation did not occur was marked with ◯, and the case where separation occurred was marked with ×. The results are shown in Tables 4-6.
本発明により、安定かつ使用感に優れたミノキシジル含有クリーム剤を提供することが可能となった。 According to the present invention, it is possible to provide a minoxidil-containing cream that is stable and excellent in usability.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013189093A JP6221536B2 (en) | 2012-10-10 | 2013-09-12 | Composition for external use |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012225263 | 2012-10-10 | ||
JP2012225263 | 2012-10-10 | ||
JP2013189093A JP6221536B2 (en) | 2012-10-10 | 2013-09-12 | Composition for external use |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2014094933A JP2014094933A (en) | 2014-05-22 |
JP2014094933A5 JP2014094933A5 (en) | 2016-10-27 |
JP6221536B2 true JP6221536B2 (en) | 2017-11-01 |
Family
ID=50938322
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013189093A Active JP6221536B2 (en) | 2012-10-10 | 2013-09-12 | Composition for external use |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6221536B2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014168193A1 (en) * | 2013-04-11 | 2014-10-16 | 大正製薬株式会社 | Composition for external use |
JP6821916B2 (en) * | 2015-02-26 | 2021-01-27 | 大正製薬株式会社 | Topical composition |
WO2020262641A1 (en) * | 2019-06-28 | 2020-12-30 | ライオン株式会社 | Method for producing oil-in-water cream |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100867052B1 (en) * | 2000-04-07 | 2008-11-04 | 다이쇼 세이야꾸 가부시끼가이샤 | Hair Growth Stimulant Compositions with Sustained Action |
JP2006176440A (en) * | 2004-12-22 | 2006-07-06 | Kinjirushi Kk | Bleaching or aging-preventing agent composition for skin and cosmetic |
JP2009173610A (en) * | 2008-01-28 | 2009-08-06 | Fujifilm Corp | Protein nanoparticles |
JP5699476B2 (en) * | 2009-08-05 | 2015-04-08 | 大正製薬株式会社 | Hair growth |
JP5622187B2 (en) * | 2009-09-08 | 2014-11-12 | 群泰生物科技股▲ふん▼有限公司 | Water-soluble minoxidil composition |
-
2013
- 2013-09-12 JP JP2013189093A patent/JP6221536B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2014094933A (en) | 2014-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7099581B2 (en) | External composition | |
JP5699476B2 (en) | Hair growth | |
JP6252475B2 (en) | External preparation composition | |
JP2023168618A (en) | Composition for external use | |
JP6819275B2 (en) | Topical solution | |
JP6221536B2 (en) | Composition for external use | |
JP7067581B2 (en) | Lotion | |
JP6424815B2 (en) | Composition for external use | |
JP5353168B2 (en) | Minoxidil-containing external preparation | |
JP6528466B2 (en) | Composition for external use | |
JP7569019B2 (en) | External Composition | |
JP6825354B2 (en) | Topical composition | |
JP2023171964A (en) | Composition for external use | |
JP2010018555A (en) | Minoxidil-containing liquid formulation | |
WO2016157542A1 (en) | Topical composition for amelioration of acne vulgaris | |
JP7575722B2 (en) | External pharmaceutical composition | |
JP2020045338A (en) | External composition | |
JP2022043342A (en) | Composition for external use | |
JP2021123586A (en) | Pharmaceutical composition for external use | |
JP2021123587A (en) | Pharmaceutical composition for external use | |
JP2021123585A (en) | Pharmaceutical preparation for external use | |
JP2021123584A (en) | Pharmaceutical preparation for external use | |
JP2021123583A (en) | Pharmaceutical preparation for external use | |
JP2018203718A (en) | External composition | |
JP2019151619A (en) | Hair composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160906 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20160906 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20170621 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170704 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170821 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20170905 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20170918 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6221536 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |